Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ARTVARTV
8 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ARTIVA BIOTHERAPEUTICS INC

CITADEL ADVISORS LLC holds 609,376 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), worth $5.9M as of 2026-Q2. The position was increased (+3739.8% shares). ARTV represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$5.9M

Current Shares

609,376

Total Value Change

+$4.4M

Total Shares Change

+505,741

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
609,376
+3739.8%
$5.9M0.0%$9.70
44
2026-Q1
New
15,870
-
$102,2030.0%$5.47
33
2025-Q4
Exited
0
-100.0%
$00.0%$4.18
0
2025-Q3
Increased
798,397
+419.3%
$2.3M0.0%$2.92
42
2025-Q2
Increased
153,739
+6.0%
$232,1460.0%$1.47
17
2025-Q1
Increased
145,089
+40.0%
$435,2670.0%$3.16
32
2024-Q4
Unchanged
103,635
0.0%
$992,4090.0%$10.58
0
2024-Q3
New
103,635
-
$1.5M0.0%$14.01
35

Other major holders of ARTV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used